On October 8, 2015, Tu Youyou, the Chinese female pharmacologist, won the 2015 Nobel Prize in physiology and medicine, becoming the first Chinese to win the Nobel Prize in naturalism. Since then, Tu Youyou has become a world-renowned medical figure in 2015. At the end of 2015, looking back on this year, although the pharmaceutical market has experienced some ups and downs, the overall market was relatively prosperous and the strength of research and development has greatly improved. At the same time, a large number of critical figures also emerged in the pharmaceutical industry this year.

Lu Xianping    

He has researched and developed China's first original new drug authorized for patent use in developed countries such as the United States

Lu Xianping, the president and chief scientific officer of Shenzhen Chipscreen Biosciences Co., Ltd. At 7 pm on May 22, 2015, Lu Xianping made a rare headline in CCTV's "news broadcast". China's first original chemical drug, Chidamide, developed by Chipscreen Biosciences and used to treat lymphoma was approved by China Food and Drug Administration (CFDA) in December last year and officially launched in March 2015. It is the first subtype selective histone deacetylase oral inhibitor to be approved for sale in the world, and the first original new drug in China to be authorized for patent use in developed countries such as the United States.

《Forbes China》- " pioneering new medicine"